Jonathan Barratt, PhD, FRCP - The Nephrology Journal Club: B-Cell Modulators and eGFR Endpoints in IgA Nephropathy

Visit https://www.peervoice.com/YYK860 to view the entire programme with slides. After completing “Jonathan Barratt, PhD, FRCP - The Nephrology Journal Club: B-Cell Modulators and eGFR Endpoints in IgA Nephropathy”, participants will be able to: Recall the safety data from trials examining novel B-cell modulator therapies in IgA nephropathy; Describe the efficacy data from trials examining novel B-cell modulator therapies in IgA nephropathy; and Appraise the clinical evidence from recent therapeutic developments, including B-cell modulators, in the context of proposed KDIGO recommended treatment targets (eg, eGFR) and approved therapies in the management of IgA nephropathy.